Drug Migraine Newly Approved

Zavzpret to treat migraine

Drug Name: Zavzpret

Indications: To treat migraine.

Active Ingredient: Zavegepant

Company: Pfizer Labs

Approval Date: 3/9/2023

More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216386s000lbl.pdf

Related

Drug Practice Process Professional Research

Elevating Healthcare Conversations through AI-Enabled CI: KAI Conversations

Drug Practice Process Professional Research

Revolutionizing Pharmacovigilance with AI: DrugCard

Drug Practice Procedure Process Professional Research

Solving for Precision Medicine with AI-Enabled Solutions: Tempus